Piers Blombery, MBBS, PhD, on More ctDNA, MRD Biomarker Use in Blood Cancer for 2024
The associate professor at Peter MacCallum Cancer Centre discussed highlights from the 2023 ASH meeting.
Piers Blombery, MBBS, PhD, on Looking Deeper Into Effects of CAR T After CAR+ Lymphoma
The associate professor at Peter MacCallum Cancer Centre discussed further research and questions that need to be investigated with the cell therapy.
Piers Blombery, MBBS, PhD, on Investigating CAR+ T-Cell Lymphoma After Cilta-Cel
The associate professor at Peter MacCallum Cancer Centre discussed case study research from the center and possible contributions to the case.